Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029874 · ClinicalTrials.gov registry record · Phase 1
Minocycline in Patients With Huntington's Disease
A Phase 1 study, sponsored by FDA Office of Orphan Products Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT00029874 is a Phase 1 study that has completed, run by FDA Office of Orphan Products Development. The registered enrollment target is 63 participants.
The verdict
NCT00029874, a Phase 1 study, has completed, sponsored by FDA Office of Orphan Products Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2001-09 |
| Est. Completion | 2003-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029874
The ClinicalTrials.gov registry entry for NCT00029874 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FDA Office of Orphan Products Development, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT00029874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029874 about?
NCT00029874 is a clinical study titled "Minocycline in Patients With Huntington's Disease". This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.
What is the current status of trial NCT00029874?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 2001-09. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00029874?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT00029874?
This trial is sponsored by FDA Office of Orphan Products Development, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.